FGFR1 overexpression renders breast cancer cells resistant to metformin through activation of IRS1/ERK signaling
{{output}}
Metformin has been suggested as an anti-cancer agent. However, increasing reports show that some tumors are resistant to metformin. Identification of factors affecting metformin mediated cancer therapy is of great significance. FGFR1 is a receptor-tyrosine-kin... ...